| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -156 | 100% | $1.88 | -$293 |
| Net | -1 | -156 | -100% | -$293 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter Virsik | Chief Operating Officer | $46,889 | 07 Oct 2024 | ||
| BVF PARTNERS L P/IL | 10%+ Owner | $0 | -$293 | -100% | 09 Oct 2025 |
| Scott Requadt | Director | $0 | 09 Oct 2025 | ||
| Marella Thorell | Director | $0 | 09 Oct 2025 | ||
| Wood David | Chief Financial Officer | $0 | 09 Oct 2025 | ||
| John Alexander Martin | Director | $0 | 09 Oct 2025 | ||
| Richard Glickman | Director | $0 | 09 Oct 2025 | ||
| David Parkinson | President and CEO, Director | $0 | 09 Oct 2025 | ||
| GROWTH N. BIOTECH V. | 10%+ Owner | $0 | 01 Nov 2024 | ||
| Franklin Berger | Director | $0 | 09 Oct 2025 | ||
| Philip W. Kantoff | Director | 25 Mar 2024 | |||
| Lauren Merendino | Director | 25 Mar 2024 | |||
| Gary Sollis | Director | 25 Mar 2024 | |||
| Alessandra Cesano | Chief Medical Officer | 25 Mar 2024 | |||
| SANFORD S. ZWEIFACH | Director | 25 Mar 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|